Natalie S de Guzman

Dr. Natalie S de Guzman

California Department of Public Health, Sacramento, California, USA
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Body Image
Verified
Journal Article
Closed access
NGNatalie S de Guzman
Natalie S de Guzman
ANAdrienne Nishina
Adrienne Nishina

6 May 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
Kelly Anne JohnsonKelly Anne Johnson
Kelly Anne Johnson
RSRobert Snyder
Robert Snyder
ETEric C. Tang
Eric C. Tang
NGNatalie S de Guzman
Natalie S de Guzman
RPRosalyn E. Plotzker
Rosalyn E. Plotzker
KJKathleen Jacobson
Kathleen Jacobson
Syphilis and congenital syphilis (CS) are increasing in California (CA). From 2015 through 2019, for example, CA cases of early syphilis among reproductive-age females (15–44) and CS each increased by >200%. Certain populations—including people experiencing homelessness, using drugs, and/or belonging to certain racial/ethnic groups—have been disproportionately impacted. We hypothesized that geospatial social determinants of health (SDH) contribute to such health inequities. To demonstrate this, we geospatially described syphilis in CA using the Healthy Places Index (HPI). The HPI is a composite index that assigns a score to each CA census tract based on eight socioeconomic characteristics associated with health (education, housing, transportation, neighborhood conditions, clean environment, and healthcare access as well as economic and social resources). We divided CA census tracts into four quartiles based on HPI scores (with the lowest quartile having the least healthy socioeconomic and environmental conditions), then used 2013–2020 CA sexually transmitted diseases surveillance data to compare overall syphilis (among adults and adolescents) and CS case counts, incidence rates (per 100,000 population or live births), and incidence rate ratios (IRRs) among these quartiles. From 2013 to 2020, across all stages of syphilis and CS, disease burden was greatest in the lowest HPI quartile and smallest in the highest quartile (8308 cases (representing 33.2% of all incidents) versus 3768 (15.1%) for primary and secondary (P&S) syphilis; 5724 (31.6%) versus 2936 (16.2%) for early non-primary non-secondary (NPNS) syphilis; 11,736 (41.9%) versus 3026 (10.8%) for late/unknown duration syphilis; and 849 (61.9%) versus 57 (4.2%) for CS; all with p < 0.001). Using the highest HPI quartile as a reference, the IRRs in the lowest quartile were 17 for CS, 4.5 for late/unknown duration syphilis, 2.6 for P&S syphilis, and 2.3 for early NPNS syphilis. We thus observed a direct relationship between less healthy conditions (per HPI) and syphilis/CS in California, supporting our hypothesis that SDH correlate with disparities in syphilis, especially CS. HPI could inform allocation of resources to: (1) support communities most in need of assistance in preventing syphilis/CS cases and (2) reduce health disparities.

13 December 2017 in Journal of Family Theory & Review
Verified
Journal Article
Closed access
PDF file
NGNatalie S de Guzman
Natalie S de Guzman
ANAdrienne Nishina
Adrienne Nishina

1 May 2026 in medRxiv
Verified
Preprint
Open access
PDF file
NLNatalie M Linton
Natalie M Linton
NBNicole O. Burghardt
Nicole O. Burghardt
NGNatalie S de Guzman
Natalie S de Guzman
RSRobert E. Snyder
Robert E. Snyder
TLTomás M. León
Tomás M. León
KJKathleen Jacobson
Kathleen Jacobson
Background: In 2022, the yearly rate of congenital syphilis (CS) cases in California reached its highest point since 1950. We explored how different prevention strategies in California could impact future CS case incidence. Methods: Scenario modeling was used to project CS incidence from 2025 through 2030 based on 2015–2024 surveillance data. We compared a baseline scenario with scenarios that modeled 1) changes in the rate of annual female syphilis cases; and 2) changes in the proportion of pregnant persons adequately treated for syphilis. We then used 2016–2023 hospitalization discharge data from California to estimate charges associated with treatment of a CS case. Results: A 5–50% reduction in the absolute rate of female syphilis cases led to a 3–30% decrease in cumulative CS cases during the projection period. Increasing the proportion of pregnant persons adequately treated for syphilis by 5–50% led to a 2–23% decrease; combining both scenarios resulted in a 4–45% reduction. In the baseline scenario, projected CS treatment-associated hospitalization charges were estimated to total $399 million. A 45% reduction in CS cases resulting from the combined interventions would reduce charges by $158 million. Discussion: Female syphilis incidence and adequate treatment during pregnancy have substantial impact on CS case incidence and associated charges. California has implemented universal syphilis screening guidelines for all people aged 15–49 years alongside interventions supporting testing and treatment of pregnant persons. Continued implementation of these interventions will result in considerable savings around CS treatment and reduced need for management of long-term sequelae.